In Brief This Week: PerkinElmer, Roche, T2 Biosystems, Co-Diagnostics, More
News items for the week of March 13, 2023.
Top Five Articles on 360Dx Last Week: Outlook for COVID-Testing Firms; FDA LDT Regulation; and More
Last week, readers were most interested in a story exploring the outlook for firms that have focused almost solely on COVID-19 testing.
Despite recent struggles, the firm remains optimistic about its position as the first and only direct-from-blood sepsis test system.
T2 Biosystems Prices $12M Public Offering
The firm is offering about 11.1 million shares of common stock and warrants to purchase up to about 22.2 million shares of common stock.
In Brief This Week: Fujifilm, BD, PerkinElmer, OpGen, More
News items for the week of Jan. 23, 2023.
Oct 14, 2022
Canaccord Downgrades T2 Biosystems to Hold
Aug 30, 2022
T2 Biosystems Regains Nasdaq Listing Requirements
Nov 4, 2021